Tenidap sodium inhibits secretory non-pancreatic phospholipase A(2) synthesis by foetal rat calvarial osteoblasts

Tenidap (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phospholipase A(2). This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase...

Descripción completa

Detalles Bibliográficos
Autores principales: Pruzanski, W., Kennedy, B. P., Bosch, H. van den, Stefanski, E., Wloch, M., Vadas, P.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365603/
https://www.ncbi.nlm.nih.gov/pubmed/18475619
http://dx.doi.org/10.1155/S0962935195000123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365603/
https://www.ncbi.nlm.nih.gov/pubmed/18475619
http://dx.doi.org/10.1155/S0962935195000123

Ejemplares similares